Branford medical technology company IsoPlexis said it has secured $135 million in new financing that it will use in part to expand its commercial and research teams globally. The Series D financing announced Thursday includes $85 million in equity securities and $50 million in debt financing through a credit facility.
The latest infusion brings the Yale spinout’s lifetime fundraising, including grants, to $203.5 million, according to Crunchbase. The company announced a $45 million Series C round in January 2020.